Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. PFE
PFE logo

PFE

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

PFE News

Rigel Pharmaceuticals Secures Global Rights for Veppanu Breast Cancer Drug

2d agoseekingalpha

Pharmaceutical Industry Pressures Germany on Drug Pricing Policy

2d agoNewsfilter

Highlights from Zacks Analyst Blog on Featured Stocks

3d agoNASDAQ.COM

Pfizer Expects to Return to High Growth by 2029

4d agoNASDAQ.COM

Pfizer's Optimistic Future Growth Outlook

4d agoFool

Analysis of S&P 500 Index Fund Investments

5d agoNASDAQ.COM

Analysis of S&P 500 ETF Investments

5d agoFool

Overview of Recent Insider Trading Activities

6d agoseekingalpha

Wall Street Major Indexes Rise as SpaceX Debut Captivates Investors

6d agoseekingalpha

Future Outlook for Obesity Drugs Market

6d agoCNBC

Future Outlook for Obesity Medications

6d agoNewsfilter

Pfizer Inc. Receives FDA Approval and Clinical Advancements

6d agoYahoo Finance

CMS Proposes Permanent Framework for Medicare Drug Price Negotiations

Jun 12 2026seekingalpha

ORIC Pharmaceuticals Gains Buy Rating, Stock Rises

Jun 12 2026seekingalpha

Pfizer's New Drug Intensifies Competition in Weight Loss Market

Jun 12 2026Fool

Pfizer Enters Weight Loss Drug Market with Berobenatide

Jun 12 2026NASDAQ.COM